Yousif Capital Management LLC Has $7.53 Million Stake in HCA Healthcare, Inc. $HCA

Yousif Capital Management LLC decreased its position in HCA Healthcare, Inc. (NYSE:HCA) by 6.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 16,209 shares of the company’s stock after selling 1,040 shares during the period. Yousif Capital Management LLC’s holdings in HCA Healthcare were worth $7,527,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Pacer Advisors Inc. lifted its stake in shares of HCA Healthcare by 6,115.3% in the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock valued at $388,309,000 after purchasing an additional 896,437 shares during the last quarter. Viking Global Investors LP raised its holdings in HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after acquiring an additional 690,773 shares during the period. Danske Bank A S bought a new position in HCA Healthcare in the 3rd quarter worth $115,530,000. Zurich Insurance Group Ltd FI increased its holdings in shares of HCA Healthcare by 3,755.9% during the 3rd quarter. Zurich Insurance Group Ltd FI now owns 269,912 shares of the company’s stock worth $115,036,000 after purchasing an additional 262,912 shares during the period. Finally, Mondrian Investment Partners LTD bought a new position in shares of HCA Healthcare during the 3rd quarter worth about $106,605,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other news, SVP Jennifer Berres sold 8,020 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the transaction, the senior vice president directly owned 11,993 shares in the company, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the transaction, the executive vice president owned 8,853 shares in the company, valued at $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 15,214 shares of company stock valued at $7,797,595 over the last ninety days. Company insiders own 1.50% of the company’s stock.

HCA Healthcare Stock Up 3.1%

NYSE:HCA opened at $504.96 on Thursday. HCA Healthcare, Inc. has a 12 month low of $314.43 and a 12 month high of $556.52. The company’s 50-day moving average price is $511.30 and its two-hundred day moving average price is $480.37. The firm has a market cap of $112.89 billion, a PE ratio of 17.79, a price-to-earnings-growth ratio of 1.45 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same period in the prior year, the business earned $6.22 earnings per share. HCA Healthcare’s quarterly revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th were given a dividend of $0.78 per share. The ex-dividend date was Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.99%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on HCA shares. KeyCorp set a $503.00 price objective on shares of HCA Healthcare in a report on Wednesday, January 28th. The Goldman Sachs Group boosted their price objective on shares of HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. Sanford C. Bernstein set a $541.00 target price on shares of HCA Healthcare in a research report on Monday, February 9th. UBS Group lifted their target price on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a research report on Monday, February 23rd. Finally, Robert W. Baird lifted their target price on shares of HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $537.73.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.